arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CYPHERPUNK TECHNOLOGIES INC.

CYPH
$0.69 ▲ +0.02 (+2.39%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
11 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Neutral
auto_awesome

Analytical Summary

CYPHERPUNK TECHNOLOGIES INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $45.6M
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -12.8%
FCF / Share $-0.66
Trailing P/E 9.9x
Price / Book 0.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.50M
— 0.0%
Net Income Profit after all expenses
$4.82M
↑ +107.1%
FCF / Share Free cash flow per share
$-0.66
↑ +58.7%

Health Breakdown

Returns
50
Cash Quality
2

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 42 quarters